Biggest News Aggregation in the World
📰 Impact Factor News

Page 7 - Impact Factor News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Impact Factor. Real-time updates on events, politics, business and more.

Abivax Presents First-Half 2022 Financial Results and Operations Update

15.09.2022 - Obefazimod global pivotal phase 3 clinical program in ulcerative colitis on track with US IRB approval granted and first-patient-in expected end of September 2022Excellent results from the obefazimod phase 2b open-label maintenance study in moderate ...
San Diego United States France General Regina Jehle Philippe Pouletty Enregistrement Universel

New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients

According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with critical information they need to guide therapy for pancreatic cancer patients. Increasingly impactful nature of research in JNCCN reflected in new high for the journal's Impact Factor, now 12.693. PLYMOUTH MEETING, Pa., Sept. 9, 2022 /PRNewswire/ -- New research in the September 2022 issue of JNCCN-Jou...
United States Mahmoudm Al Hawary Amrom Abdelrahman Ajith Goenka Facebook Nccnorg Instagram Nccnorg

National Comprehensive Cancer Network: New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients

According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with
United States Rachel Darwin Mahmoudm Al Hawary Amrom Abdelrahman Ajith Goenka Facebook Nccnorg

New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients

According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with critical information they need to guide therapy for pancreatic cancer patients. Increasingly impactful nature of research in JNCCN reflected in new high for the journal's Impact Factor, now 12.693. PLYMOUTH MEETING, Pa., Sept. 9, 2022 /PRNewswire/ -- New research in the September 2022 issue of JNCCN-Jou...
United States Mahmoudm Al Hawary Amrom Abdelrahman Ajith Goenka Facebook Nccnorg Instagram Nccnorg

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet G

DGAP-News: ABIVAX / Key word(s): StudyAbivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology 06.09.2022 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.ABIVAX PHASE 2B STUDY RESULTS OF OBEFAZIMOD (ABX4...
New York United States Region Flamande France General Pbruce Sands Hartmutj Ehrlich

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications Reports plans to apply for additional patents... | August 8, 2022
United States Massachusetts Institute Of Technology Avalon Globocare Shuguang Zhang David Jin Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science